You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for BETADINE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for BETADINE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free PVP1_SIGMA ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-959-367 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A817952 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015898248 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0655804 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for BETADINE

Last updated: July 30, 2025

Introduction

Betadine, a widely used antiseptic, is primarily formulated with povidone-iodine as its active pharmaceutical ingredient (API). The global demand for povidone-iodine in pharmaceutical, medical, and industrial applications underscores the importance of reliable API sourcing. Ensuring high-quality povidone-iodine from reputable suppliers is critical to maintaining the efficacy and safety profiles of Betadine formulations. This article provides a comprehensive analysis of the key sources for bulk povidone-iodine, including manufacturing regions, leading suppliers, and strategic considerations for pharmaceutical companies sourcing API for Betadine.


Understanding Povidone-Iodine as the API for Betadine

Povidone-iodine is a complex of polyvinylpyrrolidone (PVP) and iodine, exhibiting broad-spectrum antimicrobial activity. Its stability, solubility, and sustained-release properties make it ideal for use in topical antiseptics like Betadine. The API's quality directly influences Betadine’s safety, potency, and shelf life. Therefore, selecting high-grade povidone-iodine suppliers is crucial.


Global Manufacturing Landscape for Povidone-Iodine API

Major Production Regions

The production of povidone-iodine for API manufacturing predominantly occurs in regions with advanced chemical and pharmaceutical infrastructure. The leading manufacturing hubs include:

  • China: Dominates the global API market for povidone-iodine, with numerous large-scale chemical producers supplying both domestic and international markets. Chinese manufacturers benefit from cost-effective production, extensive R&D, and capacity to meet high-volume demands.

  • India: A significant global player, India offers high-quality povidone-iodine APIs produced by companies with robust APIs and compliance with global regulatory standards. Indian manufacturers often focus on high-purity grades suitable for pharmaceutical applications.

  • South Korea and Japan: Known for high standards of manufacturing and stringent quality control, these countries produce premium-grade povidone-iodine APIs, catering to both domestic and export markets requiring strict quality parameters.

  • Europe: While less dominant in volume, European producers focus on specialized, high-purity APIs that meet rigorous regulatory requirements (e.g., EMA, MHRA standards).

Key Sources and Leading Suppliers

1. Chinese Manufacturers

  • Shandong Qilu Bio-Technology Group Co., Ltd.: A prominent producer delivering API-grade povidone-iodine with competitive pricing and quality certifications suitable for pharmaceutical applications.

  • Qingdao Seawin Biotech Group Co., Ltd.: Offers high-quality povidone-iodine API with GMP certifications, emphasizing compliance with international standards.

  • Dengfeng Tianqing Pharmaceutical Co., Ltd.: Known for producing pharmaceutical-grade povidone-iodine APIs focused on safety and purity.

2. Indian Manufacturers

  • Shivam Organics: Supplies pharmaceutical-grade povidone-iodine API, adhering to Indian and international quality standards.

  • Lloyds Pharmaceuticals: Provides povidone-iodine APIs with WHO-GMP certifications and consistent quality.

  • Gujarat Povidone Iodine Ltd.: Specializes in various iodine-based APIs, including povidone-iodine, with globally recognized manufacturing practices.

3. Japanese and Korean Suppliers

  • Ashland Japan: Known for high-purity pharmaceutical excipients, including povidone-iodine API, meeting strict regulatory standards.

  • Kyowa Hakko Kirin (South Korea): Offers premium APIs with proven safety profiles and compliance with international regulatory standards.

4. European Suppliers

  • Fagron: Provides customized API sourcing solutions, including povidone-iodine, with a focus on European regulatory standards.

  • Sirio Pharma: Supplies high-quality APIs tailored to pharmaceutical and antiseptic formulations, emphasizing quality assurance.


Considerations for API Sourcing

Regulatory Compliance

The selected API supplier must demonstrate compliance with Good Manufacturing Practices (GMP), ISO standards, and other relevant certifications (e.g., EMA, FDA). Verifying batch consistency, impurity profiles, and stability data ensures API suitability.

Quality Certification & Testing

Certifications like Certificate of Analysis (CoA), Ph Eur or USP monographs, and third-party test reports are critical in evaluating API quality. Rigorous testing for residual solvents, heavy metals, microbial contamination, and iodine content ensures safety and efficacy.

Supply Chain Reliability

Long-term supply agreements with established manufacturers mitigate risk of shortages. Manufacturers with diversified production capacities and logistical capabilities are preferable.

Pricing & Market Dynamics

Chinese and Indian suppliers typically offer cost advantages due to manufacturing scale, but quality assurance becomes paramount. European and Japanese suppliers, while typically more expensive, may provide APIs with higher regulatory acceptance outside emerging markets.

Environmental & Ethical Sourcing

Sustainable manufacturing practices, minimal environmental impact, and ethical sourcing are increasingly vital. Suppliers adhering to environmental regulations and corporate social responsibility warrant consideration.


Emerging Trends in API Sourcing for Betadine

  • Shift towards high-purity APIs: As regulatory scrutiny intensifies, pharmaceutical companies prioritize suppliers offering APIs meeting stringent purity and safety standards.

  • Vertical integration: Manufacturers controlling raw material sourcing and production processes reduce contamination risks.

  • Digital traceability: Blockchain and digital supply chains enhance transparency and trackability of APIs.

  • Regional diversification: Companies revisit regional sourcing strategies to mitigate geopolitical risks and trade disruptions.


Conclusion

The sourcing of povidone-iodine API for Betadine production hinges on regional capabilities, quality adherence, regulatory compliance, and supply chain robustness. Leading suppliers from China, India, Japan, South Korea, and Europe serve as the primary sources, each offering distinct advantages regarding price, quality, and regulatory acceptance. Strategic sourcing should involve rigorous qualification processes, continuous quality monitoring, and supply chain diversification to ensure sustained product quality, regulatory compliance, and cost-effectiveness.


Key Takeaways

  • Chinese and Indian manufacturers dominate global povidone-iodine API supply, offering cost-effective options with varying quality assurances.
  • High-purity APIs meeting pharmacopeial standards are essential for Betadine's safety and efficacy.
  • Regulatory compliance certifications (GMP, ISO, etc.) are non-negotiable criteria in API selection.
  • Diversification of suppliers and geographic regions mitigates supply chain risks amid geopolitical and logistical challenges.
  • Growing emphasis on transparency, sustainability, and traceability influences future API sourcing strategies.

FAQs

1. What are the primary criteria for selecting a povidone-iodine API supplier for Betadine?
Criteria include GMP compliance, consistent quality, purity profiles adhering to pharmacopeial standards, reliable supply, competitive pricing, and environmental sustainability practices.

2. Which regions are considered the most reliable sources for povidone-iodine API?
China and India are leading global suppliers due to their manufacturing scale and cost advantages. Japan and South Korea offer high-quality APIs with strict regulatory compliance. Europe provides premium APIs tailored to high-standard markets.

3. How does regulatory compliance impact API sourcing for Betadine?
Regulatory compliance ensures the API meets safety and efficacy standards mandated by authorities such as the FDA or EMA, which is critical for market approval and patient safety.

4. What emerging trends should pharmaceutical companies monitor in API sourcing?
Trends include the adoption of high-purity APIs, digital traceability, vertical integration, regional diversification, and environmentally sustainable manufacturing practices.

5. How can companies mitigate risks associated with API supply shortages?
By establishing multi-supplier agreements, maintaining inventory buffers, sourcing from reputable manufacturers with diversified manufacturing bases, and continuously monitoring supply chain resilience.


References

[1] WHO. (2020). Guidelines on the quality assurance of pharmaceuticals. World Health Organization.
[2] U.S. Pharmacopeia. (2021). USP Monograph for Povidone-Iodine. United States Pharmacopeial Convention.
[3] China National Pharmaceutical Certification. (2022). Manufacturing standards and certifications.
[4] Indian Pharmacopoeia Commission. (2021). Pharmacopoeial standards for povidone-iodine.
[5] Regulatory Agencies. (2023). Global API manufacturing regulations and compliance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.